Distributed Access to Critical Biotherapeutics for Warfighters

Abstract

The goal of the Distributed Access to Critical Biotherapeutics for Warfighters program is to ensure DoD access to critical medical countermeasures (MCMs) by establishing the foundational technologies needed for fully distributable, on-demand manufacturing of protein-based MCMs and critical reagents. To achieve this, investments will be made in technologies that enable immediate, high-yield synthesis of bioactive protein MCMs. This technology will allow the DoD to rapidly secure access to therapeutic proteins and to enzymes needed for nucleic-acid based MCM synthesis without reliance on complex supply chains or slow development cycles.

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2025
Source ID
4fc1008a4d7fee1b2bc8675fba8b77da

Tags

Fields of Study

  • Engineering

Readers

  • Computer Networking
  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Molecular and Cellular Biochemistry

Technology Areas

  • Biotechnology

Related Documents